Sky View Investment Advisors, LLC Enlivex Therapeutics Ltd. Transaction History
Sky View Investment Advisors, LLC
- $698 Million
- Q2 2025
A detailed history of Sky View Investment Advisors, LLC transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 10,000 shares of ENLV stock, worth $10,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$10,400
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ENLV
# of Institutions
26Shares Held
2.81MCall Options Held
79.1KPut Options Held
0-
Armistice Capital, LLC New York, NY1.41MShares$1.47 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny612KShares$636,6880.0% of portfolio
-
Citizens Financial Group Inc231KShares$240,6800.0% of portfolio
-
Morgan Stanley New York, NY219KShares$227,9140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny168KShares$175,1270.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $19.1M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...